Dr. Nicholas Paul Luzietti M.D.

Recommended Articles

• Syphilis: If Left Untreated, What Happens to the Body?

  What is Syphilis?Syphilis is a venereal disease that is transmitted through vaginal, anal, or oral sexual contact. It can also be passed from a pregnant mother to her unborn baby, or from an infected blood donor to a person who receives the blood contaminated with syphilitic bacteria through a...

• What You Need to Know About Human Papillomavirus (HPV) Testing

  HPV is the most commonly spread sexually transmitted infection (STI). What people must know is that the HPV virus is a different virus from that of HIV and HSV (herpes). It is transmitted so often that almost everyone who participates in sexual activity will contract the virus at some time in...

• Sleep Positioners May Increase a Baby's Risk of Death

  A warning has been issued by the FDA and the Consumer Product Safety Commission (CPSC) against the use of sleep-positioning devices for babies. About 12 deaths have been reported with the use of these devices in the last 13 years.FDA principal deputy commissioner, Joshua Sharfstein, reported that...

• Ovary Removal Does Not Raise Your Risk for Heart Disease

  A review of data from a major women’s health study failed to find a significant association between ovary removal during a hysterectomy and an increased risk of heart disease. This is in contrast to the results published from another large study that reported that the risk of heart disease...

• Is Hormone Replacement Therapy Preventing Women from Getting Mammograms?

  According to a new study, the sudden drop in the rate of mammograms taken by women is due to the fear of hormone replacement therapy (HRT). Up to the year 2000, many women used to take up mammography, once every two years, as a screening method for breast cancer. By the year 2005, researchers...

• Can Melatonin Keep Breast Cancer at Bay and Improve Treatment?

  Breast cancer is the most common type of cancer among women. Today, this type of cancer generally has a good prognosis: around 80% of women have a survival rate of 10 years or longer. This is partially due to the chemotherapeutic agent known as tamoxifen. ...